 |
Articles: Marketing/Media/ROI |
Cell Therapeutics to Resume Trading on MTA and NASDAQ
Cell Therapeutics, 02/18/09
Free full text
Antigenics Receives NASDAQ Delisting Notice
Antigenics, 02/13/09
Free full text
Zila Completes First Phase of Global Marketing Initiatives for Oral Cancer Screening Product, ViziLite(R) Plus
Zila, 02/12/09
Free full text
UCB sells anti-haemorrhagic drug to Eumedica 10-February-2009
UCB, 02/11/09
Free full text
Bayer CropScience presents new herbicidal active ingredient indaziflam
BayNews International, 02/10/09
Free full text
Glaxosmithkline and genmab seek european marketing authorisation of arzerra (ofatumumab) in advanced stage blood cancer
Genmab, 02/06/09
Free full text
GlaxoSmithKline and Genmab seek European marketing authorisation of Arzerra (ofatumumab) in advanced stage blood cancer
GlaxoSmithKline, 02/06/09
Free full text
The Future of Media and Social Influence Marketing
PharmExec, 02/06/09 King Pharmaceuticals Offers New Dosage Strengths of Avinza to Provide More Treatment Options for People With Chronic Pain
King Pharmaceuticals, 02/06/09
Free full text
Publicis Aligns Messaging Divisions
PharmExec, 02/05/09 Nextrials Hits 10-Year Milestone and Surpasses Sales Expectations
Applied Clinical Trials, 02/04/09
Free full text
DeCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market
deCODE genetics, 02/04/09
Free full text
Human genome sciences begins delivery of first-in-class anthrax treatment to u.s. strategic national stockpile
Human Genome Sciences, 02/03/09
Free full text
Bayer MaterialScience at UTECH 2009 in Maastricht from March to April
BayNews International, 02/02/09
Free full text
Ciba focuses on “Making Things Better” at the European Coatings Show 2009
Ciba, 01/30/09
Free full text
Taking It Personally: Building Relationships Online
PharmExec, 01/27/09 Medtronic Starts “VITALITY,” a Post-Market Study of the Talent Abdominal Stent Graft
Medtronic, 01/27/09
Free full text
GSK to drive growth in emerging markets with acquisition of UCB products
GlaxoSmithKline, 01/26/09
Free full text
UCB to divest selected smaller markets to further focus on its key strategic areas 23-January-2009
UCB, 01/26/09
Free full text
Study: “The In-house Consulting Market in Germany”
BayNews International, 01/23/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
234 Available Pages
|
|
